Addus HomeCare (ADUS) PT Raised to $125 at Jefferies

Jefferies analyst Brian Tanquilut raised the price target on Addus HomeCare (NASDAQ: ADUS) to $125.00 (from $120.00) while maintaining a Buy rating.

The analyst commented, "ADUS's announcement of a $192MM all-cash acquisition of a hospice asset in Ohio is a notable positive as it should boost 2021 revenues by >$55MM and EBITDA by$10-$15MM (vs. current Street ests of $823MM and $85MM, respectively). Today'sacquisition also highlights mgmt's continued commitment to taking advantage of its strong balance sheet and robust FCF to pursue accretive and strategic, geographically-aligned acquisitions."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'